ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2587

Prognostic Role of Measurement of Renal Resistive Index in Systemic Sclerosis

shefali sharma1, Arghya Chattopadhyay 2, siddharth Jain 2, Varun Dhir 3, mahesh Prakash 3 and manish Rathi 2, 1Dr., Chandigarh, Chandigarh, India, 2Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India, 3Post Graduate Institute of Medical Education and Research, Chandigarh, India

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: autoimmune diseases and Diagnostic Tests, Clinical research methods

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Systemic Sclerosis & Related Disorders – Clinical Poster III

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Spectrum of vascular involvement in systemic sclerosis (SSc) is diverse like Raynaud’s phenomenon, digital ulcers, pulmonary hypertension and renal disease. Recognition of markers of subclinical disease is an area of active interest in SSc. This study was undertaken to assess the correlation of renal resistive index (RRI) with both renal and systemic vasculopathic manifestations.

Methods: In this single-centre prospective study, RRI was calculated for consecutive SSc patients classified as per the ACR/EULAR 2013 criteria. Elevated RRI ( >0.7) was correlated with renal function (eGFR and proteinuria). RRI was compared with other systemic vasculopathic manifestations like digital ulcers, digital infarcts and pulmonary hypertension.

Results: Seventy three patients (mean age= 41.79 ±10.92) were included. Mean RRI in the right and left renal artery was 0.65 ±0.082 and 0.66±0.075 respectively. Sixteen out of 73 patients (21.9%) had increased RRI ( >0.7). A negative correlation was noted between elevated RRI and eGFR (r= -0.958 p=0.026). Patients with significant proteinuria was also higher in the group with elevated RRI (r= 1), although not statistically significant (p=0.164).  Similarly, digital ulcers and infarcts/pitting were numerically higher in the group with raised RRI, although statistical significance was not reached (p=0.09 and 0.28 respectively). No correlation of RRI with pulmonary arterial hypertension was identified (r=0.009, p=0.948).

Conclusion: Measurement of RRI holds promise as a tool for assessment of subclinical renal vasculopathy and systemic vasculopathy, and needs to be addressed in larger systematically designed studies with longer follow-up.


Disclosure: s. sharma, None; A. Chattopadhyay, None; s. Jain, None; V. Dhir, None; m. Prakash, None; m. Rathi, None.

To cite this abstract in AMA style:

sharma s, Chattopadhyay A, Jain s, Dhir V, Prakash m, Rathi m. Prognostic Role of Measurement of Renal Resistive Index in Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/prognostic-role-of-measurement-of-renal-resistive-index-in-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prognostic-role-of-measurement-of-renal-resistive-index-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology